healthletic bpc 157 side effects Body Protection Compound (BPC-157) – The Hidden Risks of BPC‑157:

It can cause permanent neurological changes or fatigue

Downregulated cytokine-cytokine receptor pathway is labeled in purple box

Some patients may experience temporary irritation at the injection site

On the other hand, DSIP and CBBBP show no improvement when compared with the model group (Figure 8A)

No Current UK Marketing Authorisation Identified The official UK sources reviewed for this article did not identify a current marketing authorisation for a BPC-157 medicinal product

Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications